NTP TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF NAPHTHALENE (CAS NO. 91-20-3) IN F344/N RATS (INHALATION STUDIES)

NTP Technical Report on the Toxicology and Carcinogenesis Studies Series

Volumn TR-500, Issue , 2000, Pages 1-176

  Abdo, K M ^g   Bristol, D W ^g   Bucher, J R ^g   Chapin, R E ^g   Hailey, J R ^g   Haseman, J K ^g   Herbert, R A ^e   Maronpot, R R ^g   Melnick, R L ^g   Orzech, D P ^g   Rao, G N ^g   Roycroft, J H ^g   Smith, C S ^g   Travlos, G S ^g   Willems, B A T ^g   Witt, K L ^a   Chou, B J ^g   Grumbein, S L ^c   Weigle, R J ^g   Westerberg, R B ^g   Hardisty, J F ^g   Shackelford, C C ^f   Brecher, S ^g   Hildebrandt, P K ^b   Hamilton, B F ^d   Mahler, J ^e   Nyska, A ^e   Sills, R C ^e   Wall, H ^d   Morris, R W ^g   Betz, L J ^g   McGowan, K P ^g   Scott, J T ^g   Gunnels, S R ^g   Harper, L M ^g   Serbus, D C ^g   Sharp, W D ^g   Willis, R A ^g   more..

^a INTEGRATED LABORATORY SYSTEMS   (United States)

^b PATHCO

^c BATTELLE MEMORIAL INSTITUTE   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

^e National Toxicology Program

^f EXPERIMENTAL PATHOLOGY LABORATORIES INC   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85149230247     PISSN: 23788917     EISSN: 23788925     Source Type: Book Series    
DOI: None     Document Type: Review

References (153)

1. Abdo, K.M., Eustis, S.L., McDonald, M., Jokinen, M.P., Adkins, B., Jr., and Haseman, J.K. (1992). Naphthalene: A respiratory tract toxicant and carcinogen for mice. Inhalat. Toxicol. 4, 393-409.
2. Adkins, B., Jr., Van Stee, E.W., Simmons, J.E., and Eustis, S.L. (1986). Oncogenic response of strain A/J mice to inhaled chemicals. J. Toxicol. Environ. Health 17, 311-322.
3. The Aldrich Library of FT-IR Spectra (1985). 1st ed. (C.J. Pouchert, Ed.), Vol. 1, p. 956A. Aldrich Chemical Company, Inc., St. Louis, MO.
4. Alexandrov, K., and Frayssinet, C. (1973). Brief communication: In vivo effect of some naphthalene-related compounds on aryl hydrocarbon (benzo[a]pyrene) hydroxylase. J. Natl. Cancer Inst. 51, 1067-1069.
5. American Conference of Governmental Industrial Hygenists (ACGIH) (1999). 1999 Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati, OH.
6. Anziulewicz, J.A., Dick, H.J., and Chiarulli, E.E. (1959). Transplacental naphthalene poisoning. Am. J. Obstet. Gynecol. 78, 519-521.
7. Ashby, J., and Tennant, R.W. (1991). Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257, 229-306.
8. Bagchi, D., Bagchi, M., Balmoori, J., Vuchetich, P.J., and Stohs, S.J. (1998). Induction of oxidative stress and DNA damage by chronic administration of naphthalene to rats. Res. Commun. Mol. Pathol. Pharmacol. 101, 249-257.
9. Bailer, A.J., and Portier, C.J. (1988). Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 44, 417-431.
10. Beratergremium für Umweltrelevante Altostoffe (BUA) (1989). Naphthalene (GDCh-Advisory Committee on Existing Chemicals of Environmental Relevance, Eds.). BUA Report 39. VCH Verlagsgese, Weinheim, Germany.
11. Bieler, G.S., and Williams, R.L. (1993). Ratio of estimates, the delta method, and quantal response tests for increased carcinogenicity. Biometrics 49, 793-801.
12. Bock, K.W., van Ackeren, G., Lorch, F., and Birke, F.W. (1976). Metabolism of naphthalene to naphthalene dihydrodiol glucuronide in isolated hepatocytes and in liver microsomes. Biochem. Pharmacol. 25, 2351-2356.
13. Bock, K.W., von Clausbruch, U.C., and Winne, D. (1979). Absorption and metabolism of naphthalene and benzo(a)pyrene in the rat jejunum in situ. Med. Biol. 57, 262-264.
14. Bolonova, L.N. (1967). Effect of naphthalene and its methyl derivatives on the content of ammonia in the brain of rats. Farmakol. Toksikol. 30, 484-486.
15. Boorman, G.A., Montgomery, C.A., Jr., Eustis, S.L., Wolfe, M.J., McConnell, E.E., and Hardisty, J.F. (1985). Quality assurance in pathology for rodent carcinogenicity studies. In Handbook of Carcinogen Testing (H.A. Milman and E.K. Weisburger, Eds.), pp. 345-357. Noyes Publications, Park Ridge, NJ.
16. Bos, R.P., Theuws, J.L.G., Jongeneelen, F.J., and Henderson, P.T. (1988). Mutagenicity of bi-, tri- and tetra-cyclic aromatic hydrocarbons in the ƒtaped-plate assay≈ and in the conventional Salmonella mutagenicity assay. Mutat. Res. 204, 203-206.
17. Boyland, E., Busby, E.R., Dukes, C.E., Grover, P.L., and Manson, D. (1964). Further experiments on implantation of materials into the urinary bladder of mice. Br. J. Cancer 18, 575-581.
18. Buckpitt, A.R., and Bahnson, L.S. (1986). Naphthalene metabolism by human lung microsomal enzymes. Toxicology 41, 333-341.
19. Buckpitt, A.R., and Richieri, P. (1984). Comparative biochemistry and metabolism: Part 2. Naphthalene lung toxicity. AFAMRL-TR-84-058. Systems Command, Aerospace Medical Division, Air Force Aerospace Medical Research Laboratory, Wright-Patterson Air Force Base, OH.
20. Buckpitt, A.R., and Warren, D.L. (1983). Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo. J. Pharmacol. Exp. Ther. 225, 8-16.
21. Buckpitt, A.R., Castagnoli, N., Jr., Nelson, S.D., Jones, A.D., and Bahnson, L.S. (1987). Stereo-selectivity of naphthalene epoxidation by mouse, rat, and hamster pulmonary, hepatic, and renal microsomal enzymes. Drug Metab. Dispos. 15, 491-498.
22. Buckpitt, A., Buonarati, M., Avey, L.B., Chang, A.M., Morin, D., and Plopper, C.G. (1992). Relationship of cytochrome P450 activity and Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey. J. Pharmacol Exp. Ther. 261, 364-372.
23. Buckpitt, A., Chang, A.M., Weir, A., Van Winkle, L., Duan, X., Philpot, R., and Plopper, C. (1995). Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters. Mol. Pharmacol. 47, 74-81.
24. Buonarati, M., Jones, A.D., and Buckpitt, A. (1990). In vivo metabolism of isomeric naphthalene oxide glutathione conjugates. Drug. Metab. Dispos. 18, 183-189.
25. Chang, A., Plopper, C., Weir, A., Sassme, H., and Buckpitt, A. (1991). Correlation of species selective pulmonary toxicity to naphthalene (NA) with immunohistochemical localization of cytochrome P450MN and the stereoselective epoxidation of NA in airway explant incubations. Toxicologist 11, 59 (Abstr.).
26. Chang, L.H. (1943). Fecal excretion of polycyclic hydrocarbons following their administration to the rat. J. Biol. Chem. 151, 93-99.
27. Chemical Economics Handbook [database online] (2000). SRI International, Menlo Park, CA.
28. Chen, K.C., and Dorough, H.W. (1979). Glutathione and mercapturic acid conjugations in the metabolism of naphthalene and 1-naphthyl N-methylcarbamate (carbaryl). Drug Chem. Toxicol. 2, 331-354.
29. Code of Federal Regulations (CFR) 21, Part 58.
30. Connor, T.H., Theiss, J.C., Hanna, H.A., Monteith, D.K., and Matney, T.S. (1985). Genotoxicity of organic chemicals frequently found in the air of mobile homes. Toxicol. Lett. 25, 33-40.
31. Corner, E.D.S., and Young, L. (1954). The metabolism of naphthalene in animals of different species. Biochem. J. 58, 647-655.
32. Cox, D.R. (1972). Regression models and life-tables. J. R. Stat. Soc. B34, 187-220.
33. Crawford, B.D. (1985). Perspectives on the somatic mutation model of carcinogenesis. In Advances in Modern Environmental Toxicology. Mechanisms and Toxicity of Chemical Carcinogens and Mutagens (M.A. Mehlman, W.G. Flamm, and R.J. Lorentzen, Eds.), pp. 13-59. Princeton Scientific Publishing Co., Inc., Princeton, NJ.
34. Dawson, J.P., Thayer, W.W., and Desforges, J.F. (1958). Acute hemolytic anemia in the newborn infant due to naphthalene poisoning: Report of two cases, with investigations into the mechanism of the disease. Blood 13, 1113-1125.
35. de Bruin, A. (1976). Biochemical Toxicology of Environmental Agents, p. 1544. Elsevier/North-Holland Biomedical Press, New York.
36. Delgado-Rodriguez, A., Ortíz-Marttelo, R., Graf, U., Villalobos-Pietrini, R., and Gómez-Arroyo, S. (1995). Genotoxic activity of environmentally important polycyclic aromatic hydrocarbons and their nitro derivatives in the wing spot test of Drosophila melanogaster. Mutat. Res. 341, 235-247.
37. Dixon, W.J., and Massey, F.J., Jr. (1951). Introduction to Statistical Analysis, 1st ed., pp. 145-147. McGraw-Hill Book Company, Inc., New York.
38. Djomo, J.E., Ferrier, V., Gauthier, L., Zoll-Moreux, C., and Marty, J. (1995). Amphibian micronucleus test in vivo: Evaluation of the genotoxicity of some major polycyclic aromatic hydrocarbons found in a crude oil. Mutagenesis 10, 223-226.
39. Doherty, M.A., Makowski, R., Gibson, G.G., and Cohen, G.M. (1985). Cytochrome P-450 dependent metabolic activation of 1-naphthol to naphthoquinones and covalent binding species. Biochem. Pharmacol. 34, 2261-2267.
40. Dunnett, C.W. (1955). A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50, 1096-1121.
41. Eisele, G.R. (1985). Naphthalene distribution in tissues of laying pullets, swine, and dairy cattle. Bull. Environ. Contam. Toxicol. 34, 549-556.
42. Fanucchi, M.V., Buckpitt, A.R., Murphy, M.E., and Plopper, C.G. (1997). Naphthalene cytotoxicity of differentiating Clara cells in neonatal mice. Toxicol. Appl. Pharmacol. 144, 96-104.
43. Florin, I., Rutberg, L., Curvall, M., and Enzell, C.R. (1980). Screening of tobacco smoke constituents for mutagenicity using the Ames« test. Toxicology 15, 219-232.
44. Galloway, S.M., Armstrong, M.J., Reuben, C., Colman, S., Brown, B., Cannon, C., Bloom, A.D., Nakamura, F., Ahmed, M., Duk, S., Rimpo, J., Margolin, B.H., Resnick, M.A., Anderson, B., and Zeiger, E. (1987). Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: Evaluations of 108 chemicals. Environ. Mol. Mutagen. 10 (Suppl. 10), 1-175.
45. Gerarde, H.W. (1960). Toxicology and Biochemistry of Aromatic Hydrocarbons, pp. 225-232. Elsevier, Amsterdam.
46. Ghetti, G., and Mariani, L. (1956). Eye changes due to naphthalene. Med. Lav. 47, 524.
47. Gidron, E., and Leurer, J. (1956). Naphthalene poisoning. Lancet 1, 228-230.
48. Gosselin, R.E., Smith, R.P., and Hodge, H.C. (1984). Clinical Toxicology of Commercial Products, 5th ed., p. III-307. Williams and Wilkins, Baltimore.
49. Haddad, L.M., and Winchester, J.F. (1983). Clinical Management of Poisoning and Drug Overdose, p. 888. Saunders, Philadelphia.
50. Hansch, C., Leo, A., and Hoekman, D. (1995). QSAR¬Hydrophobic, Electronic, andStericConstants. American Chemical Society, Washington, DC.
51. Harden, R.A., and Baetjer, A.M. (1978). Aplastic anemia following exposure to paradichlorobenzene and naphthalene. J. Occup. Med. 20, 820-822.
52. Harkema, J.R., and Morgan, K.T. (1996). Proliferative and metaplastic lesions in nonolfactory nasal epithelia induced by inhaled chemicals. In Respiratory System (T.C. Jones, D.L. Dungrowth, and U. Mohr, Eds.) 2nd ed., pp. 18-28. Springer-Verlag, Berlin.
53. Hollander, M., and Wolfe, D.A. (1973). NonparametricStatisticalMethods, pp.120-123. John Wiley and Sons, New York.
54. Honda, T., Kiyozumi, M., and Kojima, S. (1990). Alkylnaphthalene. XI. Pulmonary toxicity of naphthalene, 2-methylnaphthalene, andisopropylnaphthalenes in mice. Chem. Pharm. Bull. (Tokyo) 38, 3130-3135.
55. Horning, M.G., Stillwell, W.G., Griffin, G.W., and Tsang, W.S. (1980). Expoxide intermediates in the metabolism of naphthalene by the rat. Drug Metab. Dispos. 8, 404-414.
56. Jerina, D.M., Daly, J.W., Witkop, B., Zaltzman-Nirenberg, P., and Udenfriend, S. (1970). 1, 2-Naphthalene oxide as an intermediate in the microsomal hydroxylation of naphthalene. Biochemistry 9, 147-156.
57. Jonckheere, A.R. (1954). A distribution-free k-sample test against ordered alternatives. Biometrika 41, 133-145.
58. Kaplan, E.L., and Meier, P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457-481.
59. Kawachi, T., Yahagi, T., Kada, T., Tazima, Y., Ishidate, M., Sasaki, M., and Sugiyama, T. (1980). Cooperative programme on short-term assays for carcinogenicity in Japan. IARC Sci. Publ. 27, 323-330.
60. Kennaway, E.L. (1930). Further experiments on cancer-producingsubstances. Biochem.J.24, 497-504.
61. Kirk-Othmer Encyclopedia of Chemical Technology (1978). 3rd ed. (M. Grayson, Ed.), Vol. 2, p. 704. John Wiley and Sons, New York.
62. Kirk-Othmer Encyclopedia of Chemical Technology (1979). 3rd ed. (M. Grayson and D. Eckroth, Eds.), Vol. 8, p. 367. John Wiley and Sons, New York.
63. Kirk-Othmer Encyclopedia of Chemical Technology (1981). 3rd ed. (M. Grayson and D. Eckroth, Eds.), Vol. 13, p. 466, and Vol. 15, p. 460. John Wiley and Sons, New York.
64. Knake, E. (1956). Über schwache geschwulsterzeugende Wirkung von Naphthalin und Benzol. Virchows Arch. Pathol. Anat. Physiol. 329, 141-176.
65. Koch, H.R., and Doldi, K. (1975). Naphthalene cataracts in rats of differently pigmented strains. Exp. Eye Res. 20, 180 (Abstr.).
66. Konar, N.R., Roy, H.K., and De, M.N. (1939). Naphthalenepoisoning. IndianMed.Gaz.74, 723-725.
67. Kup, W. (1978). Work-related origin of cancer in the nose, mouth, throat, larynx. Akad. Wiss. 2, 20-25.
68. Lakritz, J., Chang, A., Weir, A., Nishio, S., Hyde, D., Philpot, R., Buckpitt, A., and Plopper, C. (1996). Cellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: Bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene. J. Pharmacol. Exp. Ther. 278, 1408-1418.
69. Lezenius, A. (1902). Ein Fall von Naphthalincataract am Menschen. Klin. Monatsbl. Augenheilkd. 40, 129-140.
70. Lide, D.R., Ed. (1992). CRC Handbook of Chemistry and Physics, 73rd ed., p. 3¬327. CRC Press, Boca Raton, FL.
71. Lynch, D.W., Lewis, T.R., Moorman, W.J., Burg, J.R., Groth, D.H., Khan, A., Ackerman, L.J., and Cockrell, B.Y. (1984). Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 rats. Toxicol. Appl. Pharmacol. 76, 69-84.
72. McConnell, E.E., Solleveld, H.A., Swenberg, J.A., and Boorman, G.A. (1986). Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. JNCI 76, 283-289.
73. McElroy, E.A., Jr., Buckner, J.C., and Lewis, J.E. (1998). Chemotherapy for advanced esthesioneuroblastoma: The Mayo Clinic experience. Neurosurgery 42, 1023-1028.
74. MacGregor, R.R. (1954). Naphthalene poisoning from the ingestion of moth balls. Can. Med. Assoc. J. 70, 313-314.
75. Mahvi, D., Bank, H., and Harley, R. (1977). Morphology of a naphthalene-induced bronchiolar lesion. Am. J. Pathol. 86, 558-572.
76. Maronpot, R.R., and Boorman, G.A. (1982). Interpretation of rodent hepatocellular proliferative alterations and hepatocellular tumors in chemical safety assessment. Toxicol. Pathol. 10, 71-80.
77. Melnick, R.L., and Huff, J.E. (1993). 1, 3-Butadiene induces cancer in experimental animals at all concentrations from 6.25 to 8000 parts per million. IARC Sci. Publ. 127, 309-322.
78. Melzer-Lange, M., and Walsh-Kelly, C. (1989). Naphthalene-induced hemolysis in a black female toddler deficient in glucose-6-phosphate dehydrogenase. Pediatr. Emerg. Care 5, 24-26.
79. The Merck Index (1989). 11th ed. (S. Budavari, Ed.), p. 1008. Merck and Company, Inc., Rahway, NJ.
80. The Merck Index (1996). 12th ed. (S. Budavari, Ed.), p. 1094. Merck and Company, Inc., Whitehouse Station, NJ.
81. Mersch-Sundermann, V., Mochayedi, S., and Kevekordes, S. (1992). Genotoxicity of polycyclic aromatic hydrocarbons in Escherichia coli PQ37. Mutat. Res. 278, 1-9.
82. Miller, J.A., and Miller, E.C. (1977). Ultimate chemical carcinogens as reactive mutagenic electrophiles. In Origins of Human Cancer (H.H. Hiatt, J.D. Watson, and J.A. Winsten, Eds.), pp. 605-627. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
83. Miller, R.R., Young, J.T., Kociba, R.J., Keyes, D.G., Bonder, K.M., Calhoun, L.L., and Ayres, J.A. (1985). Chronic toxicity and oncogenicity bioassay of inhaled ethyl acrylate in Fischer 344 rats and B6C3F1 mice. Drug Chem. Toxicol. 8, 1-42.
84. Mortelmans, K., Haworth, S., Lawlor, T., Speck, W., Tainer, B., and Zeiger, E. (1986). Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ. Mutagen. 8 (Suppl. 7), 1-119.
85. Narbonne, J.F., Cassand, P., Alzieu, P., Grolier, P., Mrlina, G., and Calmon, J.P. (1987). Structure-activity relationships of the N-methylcarbamate series in Salmonella typhimurium. Mutat. Res. 191, 21-27.
86. National Institute for Occupational Safety and Health (NIOSH) (1997). NIOSH Pocket Guide to Chemical Hazards. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Washington, DC.
87. 1 Mice (Inhalation Studies). Technical Report Series No. 326. NIH Publication No. 88-2582. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
88. 1 Mice (Inhalation Studies). Technical Report Series No. 410. NIH Publication No. 92-3141. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
89. 1 Mice (Inhalation Studies). Technical Report Series No. 461. NIH Publication No. 97-3377. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
90. 1 Mice (Inhalation Studies). Technical Report Series No. 467. NIH Publication No. 98-3957. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
91. 1 Mice (Inhalation Studies). Technical Report Series No. 471. NIH Publication No. 98-3961. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
92. 1 Mice (Inhalation Studies). Technical Report Series No. 490. NIH Publication No. 99-3980. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
93. Nohmi, T., Miyata, R., Yoshikawa, K., and Ishidate, M., Jr. (1985). Mutagenicity tests on organic chemical contaminants in city water and related compounds. I. Bacterial mutagenicity tests [in Japanese, English summary]. Bull. Natl. Inst. Hyg. Sci. 103, 60-64.
94. O«Brien, K.A.F., Smith, L.L., and Cohen, G.M. (1985). Differences in naphthalene-induced toxicity in the mouse and rat. Chem. Biol. Interact. 55, 109-122.
95. Piegorsch, W.W., and Bailer, A.J. (1997). Statistics for Environmental Biology and Toxicology, Section 6.3.2. Chapman and Hall, London.
96. Pino, M.V., Valerio, M.G., Miller, G.K., Larson, J.L., Rosolia, D.L., Jayyosi, Z., Crouch, C.N., Trojanowski, J.Q., and Geiger, L.E. (1999). Toxicologic and carcinogenic effects of the Type IV phosphodiesterase inhibitor RP 73401 on the nasal olfactory tissue in rats. Toxicol. Pathol. 27, 383-394.
97. Plopper, C.G., Suverkropp, C., Morin, D., Nishio, S., and Buckpitt, A. (1992). Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. I. Histopathologic comparison of the respiratory tract of mice, rats and hamsters after parenteral administration of naphthalene. J. Pharmacol. Exp. Ther. 261, 353-363.
98. Portier, C.J., and Bailer, A.J. (1989). Testing for increased carcinogenicity using a survival-adjusted quantal response test. Fundam. Appl. Toxicol. 12, 731-737.
99. Portier, C.J., Hedges, J.C., and Hoel, D.G. (1986). Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program«s carcinogenicity experiments. Cancer Res. 46, 4372-4378.
100. Potts, A.M. (1996). Toxic responses of the eye. In CasarettandDoull«sToxicology: TheBasicScienceof Poisons (C.D. Klaassen, Ed.), 5th ed., pp. 583-616. McGraw-Hill, New York.
101. Probst, G.S., McMahon, R.E., Hill, L.E., Thompson, C.Z., Epp, J.K., and Neal, S.B. (1981). Chemically-induced unscheduled DNA synthesis in primary rat hepatocyte cultures: A comparison with bacterialmutagenicityusing218compounds. Environ. Mutagen. 3, 11-32.
102. Rao, G.N. (1996). New diet (NTP-2000) for rats in the National Toxicology Program toxicity and carcinogenicity studies. Fundam. Appl. Toxicol. 32, 102-108.
103. Rao, G.N. (1997). New nonpurified diet (NTP-2000) for rodents in the National Toxicology Program«s toxicology and carcinogenesis studies. J. Nutr. 127, 842S-846S.
104. Rathbun, W.B., Holleschau, A.M., Murray, D.L., Buchanan, A., Sawaguchi, S., and Tao, R.V. (1990). Glutathione synthesis and glutathione redox pathways in naphthalene cataract of the rat. Curr. Eye Res. 9, 45-53.
105. Rathbun, W.B., Nagasawa, H.T., and Killen, C.E. (1996a). Prevention of naphthalene-induced cataract and hepatic glutathione loss by the L-cysteine prodrugs, MTCA and PTCA. Exp. Eye Res. 62, 433-441.
106. Rathbun, W.B., Holleschau, A.M., Cohen, J.F., and Nagasawa, H.T. (1996b). Prevention of acetaminophen-andnaphthalene-inducedcataractandglutathione loss by CySSME. Invest. Opthalmol. Vis. Sci. 37, 923-929.
107. 14C-1, 3-butadiene in rats and mice: Relevance to cancer susceptibility. Toxicol. Sci. 49, 186-201.
108. Rossoff, I.S. (1974). Handbook of Veterinary Drugs, p. 377. Springer Publishing, New York.
109. Sadtler Standard Spectra. IR No. 169K; NMR No. 62M. Sadtler Research Laboratories, Philadelphia.
110. Sakai, M., Yoshida, D., and Mizusaki, S. (1985). Mutagenicity of polycyclic aromatic hydrocarbons and quinones on Salmonella typhimurium TA97. Mutat. Res. 156, 61-67.
111. Santhanakrishnan, B.R., Ranganathan, G., and Raju, V.B. (1973). Naphthalene induced haemolytic anaemia with haemoglobinuria. Indian J. Pediatr. 40, 195-197.
112. Sasaki, J.C., Arey, J., Eastmond, D.A., Parks, K.K., and Grosovsky, A.J. (1997). Genotoxicity induced in human lymphoblasts by atmospheric reaction products of naphthalene and phenanthrene. Mutat. Res. 393, 23-35.
113. Sax, N.I. (1984). Dangerous Properties of Industrial Materials, 6th ed., p. 1971. Van Nostrand Reinhold Company, New York.
114. Schmahl, D. (1955). Prüfung von Naphthalin und Anthracen auf cancerogene Wirkung an Ratten. Zeit. Krebsforsch. 60, 697-710.
115. Schmeltz, I., Tosk, J., Hilfrich, J., Horita, N., Hoffman, D., and Wynder, E.L. (1978). Bioassays of naphthalene and alkylnaphthalenes for co-carcinogenic activity: Relation to tobacco carcinogenesis. In Carcinogenesis¬A Comprehensive Survey (P.W. Jones and R.I. Freudenthal, Eds.), Vol. 3, pp. 47-60. Raven, New York.
116. Shichi, H., Tanaka, M. Jensen, N.M., and Nebert, D.W. (1980). Genetic differences in cataract and other ocular abnormalities induced by paracetamol and naphthalene. Pharmacology 20, 229-241.
117. Shopp, G.M., White, K.L., Jr., Holsapple, M.P., Barnes, D.W., Duke, S.S., Anderson, A.C., Condie, L.W., Jr., Hayes, J.R., and Borzelleca, J.F. (1984). Naphthalene toxicity in CD-1 mice: General toxicology and immunotoxicology. Fundam. Appl. Toxicol. 4, 406-419.
118. Shultz, M.A., Choudary, P.V., and Buckpitt, A.R. (1999). Role of murine cytochrome P-450 2F2 in metabolic activation of naphthalene and metabolism of other xenobiotics. J. Pharmacol. Exp. Ther. 290, 281-288.
119. Sims, P., and Grover, P.L. (1974). Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Adv. Cancer Res. 20, 165-274.
120. Snellings, W.M., Weil, C.S., and Maronpot, R.R. (1984). A two-year inhalation study of the carcinogenic potential of ethylene oxide in Fischer 344 rats. Toxicol. Appl. Pharmacol. 75, 105-117.
121. Straus, D.S. (1981). Somatic mutation, cellular differentiation, and cancer causation. JNCI 67, 233-241.
122. Summer, K.H., Rozman, K., Coulston, F., and Greim, H. (1979). Urinary excretion of mercapturic acids in chimpanzees and rats. Toxicol. Appl. Pharmacol. 50, 207-212.
123. Suter, W., and Jaeger, I. (1982). Comparative evaluation of different pairs of DNA repair-deficient and DNA repair-proficient bacterial tester strains for rapid detection of chemical mutagens and carcinogens. Mutat. Res. 97, 1-18.
124. Swenberg, J.A., Heck, Hd«A, Morgan, K.T., and Star, T.B. (1985). A scientific approach to formaldehyde risk assessment. In Risk Quantitation and Regulatory Policy: 19th Banbury Report (D.G. Hoel, R.A. Merrill, and F.P. Perera, Eds.), pp. 255-267. Cold Spring Harbor, NY.
125. Takizawa, N. (1940). Carcinogenic action of quinones. Proc. Imp. Acad. (Tokyo) 16, 309.
126. Tanooka, H. (1977). Development and applications of Bacillus subtilis test systems for mutagens involving DNA-repair deficiency and suppressible auxotrophic mutations. Mutat. Res. 42, 19-31.
127. Tao, R.V., Holleschau, A.M., and Rathbun, W.B. (1991). Naphthalene-induced cataract in the rat. II. Contrasting effects of two aldose reductase inhibitors on glutathione and glutathione redox enzymes. Opthalmic Res. 23, 272-283.
128. Tarone, R.E. (1975). Tests for trend in life table analysis. Biometrika 62, 679-682.
129. Taylor, C.J.S.O., and Russell, H. (1932). Blackwater fever and naphthalene poisoning. West Afr. Med. J. 5, 48-49.
130. Tennant, R.W., Margolin, B.H., Shelby, M.D., Zeiger, E., Haseman, J.K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., and Minor, R. (1987). Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236, 933-941.
131. Thornton-Manning, J.R., and Dahl, A.R. (1997). Metabolic capacity of nasal tissue interspecies comparisons of xenobiotic-metabilizing enzymes. Mutat. Res. 380, 43-59.
132. Tingle, M.D., Pirmohamed, M., Templeton, E., Wilson, A.S., Madden, S., Kitteringham, N.R., and Park, B.K. (1993). An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes. Biochem. Pharmacol. 46, 1529-1538.
133. Tong, S.S., Hirokata, Y., Trush, M.A., Mimnaugh, E.G., Ginsburg, E., Lowe, M.C., and Gram., T.E. (1981). Clara cell damage and inhibition of pulmonary mixed-function oxidase activity by naphthalene. Biochem. Biophys. Res. Commun. 100, 944-950.
134. Tong, S.S., Lowe, M.C., Trush, M.A., Mimnaugh, E.G., Ginsburg, E., Hirokata, Y., and Gram., T.E. (1982). Bronchiolar epithelial damage and impairment of pulmonary microsomal monooxygenase activity in mice by naphthalene. Exp. Mol. Pathol. 37, 358-369.
135. Turkall, R.M., Skowronski, G.A., Kadry, A.M., and Abdel-Rahman, M.S. (1994). A comparative study of the kinetics and bioavailability of pure and soil-adsorbed naphthalene in dermally exposed male rats. Arch. Environ. Contam. Toxicol. 26, 504-509.
136. U.S. Environmental Protection Agency (USEPA) (1980). Ambient Water Quality Criteria for Naphthalene. USEPA 440/5-80-059. NTIS PB81-117707. Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH.
137. U.S. Environmental Protection Agency (USEPA) (1990). Drinking Water Health Advisories for 15 Volatile Organic Chemicals. NTIS PB90-259821. Office of Drinking Water, Washington, DC.
138. Valaes, T., Doxiadis, S.A., and Fessas, P. (1963). Acute hemolysis due to naphthalene inhalation. J. Pediatr. 63, 904-915.
139. Van der Hoeve, J. (1906). Choreoretinitis beim Menschen durch die Einwirking von Naphthalin. Arch. Augenheilk. 56, 259.
140. van Heyningen, R. (1979). Naphthalene cataract in rats and rabbits: A resume. Exp. Eye Res. 28, 435-439.
141. Vuchetich, P.J, Bagchi, D., Bagchi, M., Hassoun, E.A., Tang, L., and Stohs, S.J. (1996). Naphthalene-induced oxidative stress in rats and the protective effects of vitamin E succinate. Free Radic. Biol. Med. 21, 577-590.
142. Wang, H., Lanza, D.L., and Yost, G.S. (1998). Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene. Arch. Biochem. Biophys. 349, 329-340.
143. Wells, P.G., Wilson, B., and Lubek, B.M. (1989). In vivo murine studies on the biochemical mechanism of naphthalene cataractogenesis. Toxicol. Appl. Pharmacol. 99, 466-473.
144. Wiley Mass Spectral Database. Spectrum No. 6075. Hewlett-Packard, Palo Alto, CA.
145. Williams, D.A. (1971). A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 27, 103-117.
146. Williams, D.A. (1972). The comparison of several dose levels with a zero dose control. Biometrics 28, 519-531.
147. 1, naphthalene and tamoxifen using human liver microsomes and human lymphocytes. Hum. Exp. Toxicol. 14, 507-515.
148. Wolf, O. (1976). Cancer among chemical workers of a naphthalene cleaning plant. Dtsch. Gesundheitsw. 31, 996-999.
149. Wolf, O. (1978). Carcinoma of the larynx in naphthalene cleaners. Z. Gesamte Hyg. 24, 737-739.
150. Zeiger, E., Haseman, J.K., Shelby, M.D., Margolin, B.H., and Tennant, R.W. (1990). Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: Confirmation of earlier results with 41 additional chemicals. Environ. Mol. Mutagen. 16 (Suppl. 18), 1-14.
151. Zheng, J., Cho, M., Jones, A.D., and Hammock, B.D. (1997). Evidence of quinone metabolites of naphthalene covalently bound to sulfur nucleophiles of proteins of murine Clara cells after exposure to naphthalene. Chem. Res. Toxicol. 10, 1008-1014.
152. Zinkham, W.H., and Childs, B. (1958). A defect of glutathione metabolism in erythrocytes from patients with naphthalene-induced hemolytic anemia. Pediatrics 22, 461-471.
153. Zuelzer, W.W., and Apt, L. (1949). Acute hemolytic anemia due to naphthalene poisoning. J. Am. Med. Assoc. 141, 185-190.